EVALUATION OF PHARMACOVIGILANCE AWARENESS, ATTITUDES, AND REPORTING PRACTICES OF ADVERSE DRUG REACTIONS IN COMMUNITY PHARMACIES - AN ARMENIAN EXPERIENCE

被引:0
|
作者
Barseghyan, Anush barsegh [1 ]
Dzoagbe, Hellen yayra [2 ]
Nazaryan, Lusine gagik [1 ]
Simonyan, Marta hektor [1 ]
机构
[1] Yerevan State Med Univ, Koryun 2, Yerevan, Armenia
[2] Datta Meghe Inst Higher Educ & Res DU, Datta Meghe Coll Pharm, Sawangi 442001, Meghe, India
关键词
adverse drug reactions; pharmacovigilance; community pharmacists; HEALTH-CARE PROFESSIONALS; KNOWLEDGE;
D O I
10.31925/farmacia.2025.1.24
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adverse drug reactions (ADRs) represent a significant global health issue, imposing serious risks to patient safety and incurring substantial healthcare costs. This study aimed to evaluate the knowledge, attitudes, and practices of community pharmacists in Armenia regarding pharmacovigilance and ADR reporting, Aidentifying barriers and gaps to improve ADR management within community pharmacies. AAAcross-sectional study was conducted with 590 community pharmacists selected using a random sampling technique. A validated questionnaire assessed socio-demographic characteristics, knowledge, attitudes, and practices related to pharmacovigilance. Data were analysed using SPSS version 23.0. The majority of respondents were aged 26-30 years (60.7%) and predominantly female (89.7%). Knowledge regarding pharmacovigilance was insufficient, with 71.4% of participants unfamiliar with its concepts. Only 9.3% consistently reported ADRs, reflecting significant gaps in practice. While most recognized the importance of pharmacovigilance in drug safety, confidence in their reporting abilities was low, with 78.3% not believing pharmacists should encourage patient reporting of ADRs. Challenges such as lack of knowledge, time constraints, and perceived inefficiencies in the reporting system were prevalent. The findings highlight critical deficiencies in knowledge and practice among community pharmacists concerning ADR reporting. Targeted educational programs and resources, such as training workshops and informative booklets, are essential to enhance pharmacists' engagement in pharmacovigilance efforts, ultimately improving drug safety and patient care.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 50 条
  • [21] Stakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study
    David O. Riordan
    Mary Kinane
    Kieran A. Walsh
    Frances Shiely
    Joe Eustace
    Margaret Bermingham
    European Journal of Clinical Pharmacology, 2020, 76 : 1363 - 1372
  • [22] Attitudes to reporting adverse drug reactions in northern Sweden
    Martin Bäckström
    Tom Mjörndal
    Rune Dahlqvist
    Torborg Nordkvist-Olsson
    European Journal of Clinical Pharmacology, 2000, 56 : 729 - 732
  • [23] Attitudes to reporting adverse drug reactions in northern Sweden
    Bäckström, M
    Mjörndal, T
    Dahlqvist, R
    Nordkvist-Olsson, T
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (9-10) : 729 - 732
  • [24] Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
    Tandon, Vishal R.
    Mahajan, Vivek
    Khajuria, Vijay
    Gillani, Zahid
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (01) : 65 - 71
  • [25] Adverse drug reactions in adolescents: a review of reporting to a national pharmacovigilance system
    Rebelo Gomes, Eva
    Ribeiro-Vaz, Ines
    Santos, Cristina Costa
    Herdeiro, Maria Teresa
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 915 - 922
  • [26] Evaluation of adverse drug reactions in a pharmacy department: four years of experience of a pharmacovigilance program
    Furelos, Tania Gonzalez
    Legazpi, Iria Rodriguez
    Bueno, Eva Fraga
    Lopez, Monica Granero
    Penin, Isaura Rodriguez
    PHARMACEUTICAL CARE ESPANA, 2025, 27
  • [27] Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process
    Kopciuch, Dorota
    Zaprutko, Tomasz
    Paczkowska, Anna
    Ratajczak, Piotr
    Zielinska-Tomczak, Lucja
    Kus, Krzysztof
    Nowakowska, Elzbieta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (12) : 1543 - 1551
  • [28] Exploring Healthcare Professionals' Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions
    Srisuriyachanchai, Warisara
    Cox, Anthony R.
    Jarernsiripornkul, Narumol
    HEALTHCARE, 2022, 10 (06)
  • [29] Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center
    Saint-Martin, Caroline
    Kanagaratnam, Lukshe
    de Boissieu, Paul
    Azzouz, Brahim
    Abou Taam, Malak
    Trenque, Thierry
    THERAPIE, 2016, 71 (05): : 467 - 473
  • [30] Pharmacovigilance and adverse drug reactions reporting: Dispensing pharmacists' knowledge and practices in Ille-et-Vilaine (Brittany)
    Laudren, C.
    Osmont, M. N.
    Bellissant, E.
    Polard, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 192 - 192